stood why. The findings from this IIT suggest shifts in the skin and adiposetissue profile that may help explain the volumerelated changes clinicians are seeing. By clarifying the biological underpinnings, we can better guide treatment planning, and the available science indicates that regenerative and adipose tissuestimulating treatments such as Sculptra, can play a critical role in supporting healthylooking volume and appearance. This insight gives clinicians a stronger, evidencebased foundation for thoughtful, individualized treatment discussions with their patients across their weight loss journey.”



DR. SABRINA FABI
STUDY LEAD INVESTIGATOR AND COSMETIC DERMATOLOGIST

SAN DIEGO, UNITED STATES








About Galderma

Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, scie
=*=*=*=*=*=
当前为第9/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页